Table 4.
Series | Mean of SUVmax lesion | Difference SUVmax lesion | CI 95% of Difference of SUVmax lesion | p adjusted | Bias (%) |
---|---|---|---|---|---|
QC4 | 8.91 | ||||
SQC1 | 8.30 | 0.49 | (− 0.27–1.31) | 0.187 | − 5 |
SQC2 | 7.52 | 0.96 | (0.45–1.58) | 0.002 | − 15 |
SQC3 | 7.61 | 1.17 | (0.74–1.72) | < 0.001 | − 16 |
SQC4 | 7.41 | 1.41 | (0.93–1.88) | < 0.001 | − 18 |
VP4 | 7.70 | ||||
SVP1 | 6.67 | 0.97 | (0.11–1.91) | 0.036 | − 14 |
SVP2 | 6.82 | 0.95 | (0.54–1.78) | 0.006 | − 16 |
SVP3 | 6.67 | 1.08 | (0.6–1.75) | 0.006 | − 18 |
SVP4 | 6.72 | 1.18 | (0.83–1.56) | 0.001 | − 17 |
Difference = Gold standard—study series; Bias = (Study series—Gold standard)/Gold standard